Sporotrichosis Outburst after Cancer Chemotherapy in a Dog

Background: Sporotrichosis is a dermatozoonosis that affects mammals in general, with the domestic feline (Felis catus) being the most epidemiologically important species. However, diagnosis of this disease in dogs is important considering the proximity with people and with other communicants. The epidemiology of sporotrichosis is already known in some states of Brazil, especially in the southeast region, but to the best of our knowledge there are no reports of sporotrichosis in non-human species in the state of Espírito Santo. This paper aimed at describing the first case of canine sporotrichosis in Espírito Santo, Brazil.Case: A 10 year-old Bull Terrier male dog was presented with nodular non-ulcerated lesions on the head and nodular ulcerated lesion on the nasal planum. The dog had a previous diagnosis of a low-grade mast cell tumour and palpebral melanoma. Mast cell tumour was treated with scrotum ablation (and orchiectomy) and bilateral inguinal lymph node removal, followed by chemotherapy with twelve intravenous infusion of vinblastine, along with prednisolone. Cutaneous lesions in the head and nasal planum appeared two months after finishing chemotherapy. At further anamnesis, the pet´s responsible reported that the dog had the habit of hunting cats that entered the residence, which raised the hypothesis of sporotrichosis. An undiagnostic cytology was performed, followed by a fungal culture, positive for Sporothrix schenckii. Treatment was then initiated with itraconazol (Oficial generic drug), at a dose of 10mg/kg/SID, until clinical remission, obtained after 60 days, maintaining it for 60 more days. Patient showed completed recovery, with no further complatints after a follow-up of more than 220 days.Discussion: Sporotrichosis is considered a rare disease in dogs, with isolated cases in the literature. The dog of the present report was diagnosed with sporotrichosis two months after the end of a chemotherapy treatment for a mast cell tumour. Therefore, it is suggested that the patient in this study was infected during an immunosuppressive phase. The same can occur with other immunosuppressive treatments, such as glucocorticoid, also included in the chemotherapy treatment of this patient, calcineurin inhibitors (cyclosporine) and mercaptopurine derivatives (azathioprine). Cytology is usually unconclusive for such lesions in dogs, once only a few yeast might be present. Nevertheless, the definitive diagnosis was obtained through fungal microculture. Treatment with itraconazol was successful but dogs might also present favorable responses to ioidine. Itraconazole is a fungistatic drug, fungicidal only in high doses. For this reason, if the fungistatic dose is not administered for sufficient time, recurrences may occur. In the last three years, Espirito Santo has become a new epidemiological scenario for sporotrichosis, and it is placed in the route of transmission, closely to Rio de Janeiro. Cats are the most affected animals and are commonly responsible for transmission to other species, including humans. The increase in cases of canine sporotrichosis requires its inclusion in the differential diagnosis of nodular-ulcerative lesions, along with cutaneous neoplasias and immune-mediated diseases

Estudo retrospectivo de retrovírus por teste imunoenzimático em gatos na Grande Vitória (ES, Brasil) e neoplasias associadas

As retroviroses encontram-se entre as principais causas de morte em gatos domésticos. Os retrovírus associam-se à célula hospedeira de forma persistente e permanente, levando a quadros clínicos diversos. O vírus da leucemia felina (FeLV) é oretrovírus mais patogênico, com potencial para ocasionar tanto doenças degenerativas e imunossupressão, quanto doenças proliferativas, pois sua associação à célula pode levar ao efeito oncogênico direto. Já o vírus da imunodeficiência felina (FIV), pode levar à clássica síndrome de imunodeficiência, costuma ter um curso crônico, menos agressivo e não possui efeito oncogênico direto. O uso de vacinas e de medidas de controle resultaram em redução da prevalência de FeLV nos Estados Unidos da América (EUA) e Europa, entretanto, no Brasil, determinadas regiões podem apresentar prevalências superiores a 50%. Esse estudo teve como objetivo avaliar a prevalência das retroviroses felinas, pelo teste de ensaio imunoenzimático, na região da Grande Vitória, no Espírito Santo, apontando ainda, a frequência de neoplasias nesses gatos. Um total de 388 gatos foram retrospectivamente avaliados (2014-2016). A prevalência de FIV foi de 2,3% e de FeLV 33,7%. Neoplasias foram identificadas nos três gatos sororeagentes para FIV e FeLV e em três gatos infectados apenas por FIV. Constatou-se a presença de neoplasias ainda em 26,6% dos gatos sororeagentes apenas para FeLV, com destaque para o linfoma na forma mediastinal. A elevada prevalência de FeLV demonstrada neste estudo aponta sobre a necessidade da instituição de medidas efetivas de controle, com destaque para a vacinação

Fungi predatory activity on embryonated Toxocara canis eggs inoculated in domestic chickens (Gallus gallus domesticus) and destruction of second stage larvae

The objective of this study was to evaluate the infectivity of Toxocara canis eggs after interacting with isolated nematophagous fungi of the species Duddingtonia flagrans (AC001) and Pochonia chlamydosporia (VC4), and test the predatory activity of the isolated AC001 on T. canis second stage larvae after 7 days of interaction. In assay A, 5000 embryonated T. canis eggs previously in contact with the AC001 and VC4 isolated for 10 days were inoculated into domestic chickens (Gallus gallus domesticus), and then these animals were necropsied to collect material (digested liver, intestine, muscles and lungs) at 3-, 7-, 14-, and 21-day intervals after inoculation. In assay A, the results demonstrated that the prior interaction of the eggs with isolated AC001 and VC4 decreases the amount of larvae found in the collected organs. Difference (p < 0.01) was observed in the medium larvae counts recovered from liver, lung, intestine, and muscle of animals in the treated groups when compared to the animals in the control group. At the end of assay A, a percentage reduction of 87.1 % (AC001) and 84.5 % (VC4) respectively was recorded. In the result of assay B, the isolated AC001 showed differences (p < 0.01) compared to the control group, with a reduction of 53.4 % in the recovery of L2. Through these results, it is justified to mention that prior interaction of embryonated T. canis eggs with the tested fungal isolates were efficient in reducing the development and migration of this parasite, in addition to the first report of proven predatory activity on L2

Statistical experimental design to assess the influence of enzymes of nematophagous fungi versus helminths

The present work used Plackett–Burman experimental design to assess the influence of enzymes of nematophagous fungi versus Strongyloides westeri and trichostrongylides larvae and Platynosomum fastosum eggs. The variables studied in the Plackett–Burman design were the proteases and chitinases of AC001 or VC4 as destructive agents of S. westeri and trichostrongylides larvae, and P. fastosum eggs. All tested enzymes had a significant effect (P < 0.05) on the destruction of S. westeri larvae. Furthermore, only VC4 and AC001 proteases showed a significant effect (P < 0.05) on the destruction of trichostrongylides larvae. On the other hand, chitinases of VC4 showed the highest significance (P < 0.05) on the destruction of P. fastosum eggs. It is proposed that statistical planning for the use of enzymes derived from nematophagous fungi is a viable way to elucidate some questions about their mechanism of action

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0&nbsp;±&nbsp;10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n&nbsp;=&nbsp;6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n&nbsp;=&nbsp;15,449, 56.1%) and North America (n&nbsp;=&nbsp;8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH